Friday, February 19, 2021
12:00-1:00 PM CST via Zoom
Psychiatrist Aaron Fink, M.D. explores the relationship between ADHD and Substance Use Disorders, as well as the use of stimulants in treatment.
About the Presentation:
Because individuals with Attention Deficit/Hyperactivity Disorder (ADHD) are at an increased risk for Substance Use Disorders (SUD), these issues commonly co-occur. Though psychosocial interventions have been the primary treatment for SUD, pharmacotherapy, most commonly psychostimulants, is the primary treatment for ADHD, and many providers are uncomfortable with the idea of using stimulants in those dealing with an SUD. In this presentation, board-certified psychiatrist Dr. Aaron Fink will discuss the relationship between ADHD and SUD, as well as the controversy regarding the use of stimulants and alternative treatment options in individuals with co-occurring disorders.
About the Presenter:
Aaron H. Fink, M.D. is a board certified child, adolescent and adult psychiatrist who uses biological, psychosocial and sociological factors to guide his clinical work. This developmental biopsychosocial model has shown to be particularly helpful with athletes, as well as those dealing with ADHD and eating disorders. Dr. Fink studied child development and early childhood education at the University of Texas at Austin before obtaining his medical degree from the Baylor College of Medicine, going on to complete a residency in general psychiatry and a fellowship and Chief Resident position in child and adolescent psychiatry. Dr. Fink is also an active member of many professional organizations, including his role as President of the Houston Psychotherapy Society and a founding member of the Attention Deficit Disorder Association (Southern Region).